Zobrazeno 1 - 10
of 41
pro vyhledávání: '"JR Teagarden"'
Publikováno v:
Value in Health. 21:S93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b905f090327107d7f7f362a5231545e
https://doi.org/10.1016/j.jval.2018.04.628
https://doi.org/10.1016/j.jval.2018.04.628
Publikováno v:
Intensive Care Medicine Experimental
New antibiotics have been introduced over the years to overcome drug resistance, but even these antibiotics have lost their efficacy against important Gram-negative bacteria with resistance to these drugs increasing rapidly across Europe and adjacent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdc6227f8329c06f88d155f76c1481a
http://europepmc.org/articles/PMC4797750
http://europepmc.org/articles/PMC4797750
Autor:
Sarah Garner, J Raine, J Maraganore, Y Le Cam, Lynn G. Baird, Brigitte Bloechl-Daum, M Skinner, Tatsuya Kondo, P Huckle, Trusheim, Wim G. Goettsch, Hubert G. M. Leufkens, Anton Hoos, H G Eichler, D. Samaha, J Ferguson, E Pezalla, JR Teagarden, Gigi Hirsch, R Barker, Toshiyoshi Tominaga, R Chua, Thomas F. Unger, Carole Longson, Kenneth A. Oye, Guido Rasi, Jeffrey S. Brown, Spiros Vamvakas, S Del Signore, S. Tunis, PD Siviero, U Dugan, Peter Honig, Tomas Salmonson, Robyn Lim, J Haigh, Murray Lumpkin, F Børlum‐Kristensen, Brian O'Rourke, Sebastian Schneeweiss, Francesco Pignatti
Publikováno v:
Clinical Pharmacology and Therapeutics
The concept of adaptive licensing (AL) has met with considerable interest. Yet some remain skeptical about its feasibility. Others argue that the focus and name of AL should be broadened. Against this background of ongoing debate, we examine the envi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31af74ff579e5ce5f1309473c8d62887
http://hdl.handle.net/2108/247946
http://hdl.handle.net/2108/247946
Autor:
Teagarden JR
Publikováno v:
American journal of pharmaceutical education [Am J Pharm Educ] 2020 Apr; Vol. 84 (4), pp. 7636.
Autor:
Caplan A; Division of Medical Ethics, NYU School of Medicine, New York, New York, USA., Teagarden JR; Independent Consultant, Brookfield, Connecticut, USA., Bacher HP; Global Medical Affairs, Abbvie, Inc., North Chicago, Illinois, USA., Jarvis MF; Global Medical Affairs, Abbvie, Inc., North Chicago, Illinois, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Sep; Vol. 106 (3), pp. 494-497. Date of Electronic Publication: 2019 Apr 12.
Autor:
Barlow JF; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: jfbarlow@mit.edu., Yang M; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA, USA., Teagarden JR; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2019 Jun; Vol. 22 (6), pp. 642-647. Date of Electronic Publication: 2019 May 17.
Autor:
Caplan AL; Division of Medical Ethics, NYU School of Medicine, New York City, New York, USA., Teagarden JR; Brookfield, Connecticut, USA., Kearns L; Division of Medical Ethics, NYU School of Medicine, New York City, New York, USA., Bateman-House AS; Division of Medical Ethics, NYU School of Medicine, New York City, New York, USA., Mitchell E; Department of Medical Oncology, Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, Pennsylvania, USA., Arawi T; Salim El-Hoss Bioethics & Professionalism Program, Faculty of Medicine, American University of Beirut & Medical Center, Beirut, Lebanon., Upshur R; Dalla Lana Faculty of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Sinai Health System, Toronto, Ontario, Canada., Singh I; Department of Psychiatry, Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK., Rozynska J; Center for Bioethics & Biolaw, Institute of Philosophy, University of Warsaw, Warsaw, Poland., Cwik V; Muscular Dystrophy Association, Tucson, Arizona, USA., Gardner SL; Department of Pediatrics, NYU Langone Health, New York City, New York, USA.
Publikováno v:
Journal of medical ethics [J Med Ethics] 2018 Nov; Vol. 44 (11), pp. 761-767. Date of Electronic Publication: 2018 Jul 07.
Autor:
Irani P; a AstraZeneca , Luton, Bedfordshire , UK., Salimi T; b Formerly AstraZeneca , London , UK., Epstein R; c Epstein Health LLC , Woodcliff Lake , NJ , USA., Leone-Perkins M; d HealthiVibe LLC , Arlington , VA , USA., Aubert R; e Research and Evaluation Analytics , Ringwood , NJ , USA., Khalid M; e Research and Evaluation Analytics , Ringwood , NJ , USA., Epstein E; c Epstein Health LLC , Woodcliff Lake , NJ , USA., Teagarden JR; c Epstein Health LLC , Woodcliff Lake , NJ , USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2017 Aug; Vol. 33 (8), pp. 1467-1472. Date of Electronic Publication: 2017 May 25.
Autor:
Epstein RS; Epstein Health, Woodcliff Lake, NJ, USA., Teagarden JR; Epstein Health, Woodcliff Lake, NJ, USA. rteagarden@epsteinhealth.com., Cimen A; AstraZeneca, Cambridge, UK., Sostek M; AstraZeneca, Gaitherburg, MD, USA., Salimi T; AstraZeneca, Gaitherburg, MD, USA.
Publikováno v:
Advances in therapy [Adv Ther] 2017 Mar; Vol. 34 (3), pp. 725-731. Date of Electronic Publication: 2017 Feb 08.
Autor:
Wanner A; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Groft SC; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Teagarden JR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Krischer J; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Davis BR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Coffey CS; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Hickam DH; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Teckman J; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Nelson DR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., McCaleb ML; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Loomba R; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Strange C; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Sandhaus RA; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Brantly M; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Edelman JM; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Farrugia A; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida.
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2015 Apr 28; Vol. 2 (2), pp. 177-190. Date of Electronic Publication: 2015 Apr 28.